Skip to main content

Advertisement

SpringerLink
Log in

Genotype and allele frequencies of polymorphic CYP2E1 in the Turkish population

  • Toxicokinetics and Metabolism
  • Published:
Archives of Toxicology Aims and scope Submit manuscript

Abstract

Cytochrome P4502E1 (CYP2E1) gene shows genetic polymorphisms that vary markedly in frequency among different ethnic and racial groups. We studied the genotype distributions and allele frequencies of three CYP2E1 polymorphisms: CYP2E1*5B (RsaI/PstI RFLP, C-1053T/G-1293C SNP, rs2031920 /rs3813867), CYP2E1*6 (DraI RFLP, T7632A SNP, rs6413432), and CYP2E1*7B (DdeI RFLP, G-71T SNP, rs6413420) by PCR/RFLP technique in a sample of 206 healthy subjects representing Turkish population. CYP2E1*5B polymorphism analysis yielded the genotype distribution as 96.12% for *1A/*1A (c1/c1), and 3.88% for *1A/*5B (c1/c2). The genotype frequencies for CYP2E1*6 polymorphism were found as 83.98% for *1A/*1A (T/T), 15.53% for *1A/*6 (T/A) and 0.49% for *6/*6 (A/A). For CYP2E1*7B (G-71T) polymorphism, the genotype frequencies were determined to be 86.89% for *1A/*1A (G/G), 12.62% for *1A/*7B (G/T) and 0.49% for *7B/*7B (T/T). Accordingly, the allele frequencies for *5B, *6 and *7B were 1.94, 8.25, and 6.80%, respectively. The genotype distributions of CYP2E1*5B and *6 in Turkish population were similar to those in other Caucasian populations, while differed significantly from East Asian populations. Recently, a novel and functionally important CYP2E1*7B polymorphism was identified in the promoter region. There have been few studies and limited data on CYP2E1*7B polymorphism frequency in the world and, so far, no information has been available for Turkish population. The genotype frequencies of CYP2E1*7B in Turkish population were found to be similar to those of other Caucasian populations. Population studies like this could be useful in assessing the susceptibility of different populations to chemical-induced diseases, including several types of cancer.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  • Ada AO, Süzen SH, Iscan M (2004) Polymorphisms of cytochrome P450 1A1, gluthatione S-transferases M1 and T1 in a Turkish population. Toxicol Lett 151:311–315

    Article  PubMed  CAS  Google Scholar 

  • Aktas D, Ozen H, Atsu N, Tekin A, Sozen S, Tuncbilek E (2001) Glutathione S-transferase M1 gene polymorphism in bladder cancer patients: a marker on invasive bladder cancer? Cancer Genet Cytogen 125:1–4

    Article  CAS  Google Scholar 

  • Arinç E, Adali O (1983) Solubilization and partial purification of 2 forms of cytochrome P-450 from trout liver microsomes. Comp Biochem Phys B 76:653–662

    Article  Google Scholar 

  • Arinç E, Adali O, Gencler-Ozkan AM (2000a) Induction of N-nitrosodimethylamine metabolism in liver and lung by in vivo pyridine treatments of rabbits. Arch Toxicol 74:329–334

    Article  Google Scholar 

  • Arinç E, Adali O, Gençler-Özkan AM (2000b) Stimulation of aniline, p-nitrophenol and N-nitrosodimethylamine metabolism in kidney by pyridine treatments of rabbits. Arch Toxicol 74:527–532

    Article  Google Scholar 

  • Arinç E, Arslan S, Adali O (2005) Differential effects of diabetes on CYP2E1 and CYP2B4 proteins and associated drug metabolizing enzyme activities in rabbit liver. Arch Toxicol 79(8):427–433

    Article  PubMed  CAS  Google Scholar 

  • Arinç E, Arslan S, Bozcaarmutlu A, Adali O (2007) Effects of diabetes on rabbit kidney and lung CYP2E1 and CYP2B4 expression and drug metabolism and potentiation of carcinogenic activity of N-nitrosodimethylamine in kidney and lung. Food Chem Toxicol 45(1):107–118

    Article  PubMed  CAS  Google Scholar 

  • Arinç E, Philpot RM (1976) Preparation and properties of partially purified pulmonary cytochrome P-450 from rabbits. J Biol Chem 25:3213–3220

    Google Scholar 

  • Aynacioglu AS, Brockmoller J, Bauer S, Sachse C, Guzelbey P, Ongen Z, Nacak M, Roots I (1999) Frequency of cytochrome P4502C9 variants in a Turkish population and functional relevance for phenytoin. Br J Clin Pharmacol 48:409–415

    Article  PubMed  CAS  Google Scholar 

  • Balta G, Yuksek N, Ozyurek E, Ertem U, Hicsonmez G, Altay C, Gurgey A (2003) Characterization of MTHFR, GSTM1, GSTT1, GSTP1, and CYP1A1 Genotypes in Childhood Acute Lymphoblastic Leukemia. Am J Hematol 71:154–160

    Article  CAS  Google Scholar 

  • Bolt HM, Roos PH, Thier R (2003) The cytochrome P-450 isoenzyme CYP2E1 in the biological processing of industrial chemicals: consequences for occupational and environmental medicine. Int Arch Occup Environ Health 76:174–185

    PubMed  CAS  Google Scholar 

  • Bouchardy C, Hirvonen A, Coutelle C, Ward PJ, Dayer P, Benhamou S (2000) Role of alcohol dehydrogenase 3 and cytochrome P-4502E1 genotypes in susceptibility to cancers of the upper aerodigestive tract. Int J Cancer 87:734–740

    Article  PubMed  CAS  Google Scholar 

  • Brockmöller J, Cascorbi I, Kerb R, Roots I (1996) Combined analysis of inherited polymorphisms in arylamine N-acetyltransferase 2, glutathione S-transferases M1 and T1, microsomal epoxide hydrolase, and cytochrome P450 enzymes as modulators of bladder cancer risk. Cancer Res 56(17):3915–3925

    PubMed  Google Scholar 

  • El-Zein R, Zwischenbergher JB, Wood TG, Abdel Rahman SZ, Brekelbaum C, Au WW (1997) Combined genetic polymorphism and risk for development of lung cancer. Mutat Res 381:189–200

    PubMed  CAS  Google Scholar 

  • Ernstgard L, Warholm M, Johanson G. (2004) Robustness of chlorzoxazone as an in vivo measure of cytochrome P450 2E1 activity. Br J Clin Pharmacol 58(2):190–200

    Article  PubMed  CAS  Google Scholar 

  • Fairbrother A, Grove J, de Waziers I, Steimel DT, Day CD, Crespi CL, Daly AK (1998) Detection and characterization of novel polymorphisms in the CYP2E1 gene. Pharmacogenetics 8:543–552

    Article  PubMed  CAS  Google Scholar 

  • Farker K, Lehmann MH, Oelschlagel B, Haerting J, Hoffmann A, Janitzky V, Schubert J (1998) Impact of CYP2E1 genotype in renal cell and urothelial cancer patients. Exp Toxicol Pathol 50:425–431

    PubMed  CAS  Google Scholar 

  • Garte S, Gaspari L, Alexandrie A-K, Ambrosone C, Autrup H, Autrup JI, Baranova H, Bathum L, Benhamou S, Boffetta P, Bouchardy C, Breskvar K, Brockmöller J, Cascorbi I, Clapper ML, Coutelle C, Daly A, Dell’Omo M, Dolzana V, Dresler CM, Fryer A, Haugen A, Hein DW, Hildesheim A, Hirvonen A, Hsich L-L, Ingelman-Sundberg M, Kalina I, Kang D, Kihara M, Kiyohara C, Kremers P, Lazarus P, Le Marchand L, Lechner MC, Lieshout EMM, London S, Manni JJ, Maugard CM, Morita S, Nazar-Stewart V, Noda K, Oda Y, Parl FF, Pastorelli R, Persson I, Peters WHM, Rannug A, Rebbeck T, Risch A, Roelandt L, Romkes M, Ryberg D, Salagovic J, Schoket B, Seidegard J, Shileds PG, Sim E, Sinhet D, Strange RC, Stücker I, Sugimura H, To-Figueras J, Vineis P, Yu MC, Taioli E (2001) Metabolic gene polymorphism frequencies in control populations. Cancer Epidemiol. Biomarkers Prev 10:1239–1248

    PubMed  CAS  Google Scholar 

  • Guengerich FP, Kim DH, Iwasaki M (1991) Role of human cytochrome P450 IIE1 in the oxidation of many low molecular weight cancer suspects. Chem Res Toxicol 4:168–179

    Article  PubMed  CAS  Google Scholar 

  • Haufroid V, Buchet JP, Gardinal S, Lison D (2002) Cytochrome P4502E1 phenotyping and the measurement of the chlorzoxazone metabolic ratio: assessment of its usefulness in workers exposed to styrene. Int Arch Occup Environ Health 75:453–458

    Article  PubMed  CAS  Google Scholar 

  • Hayashi S, Watanabe J, Kawajiri K (1991) Genetic polymorphisms in the 5′-flanking region change transcriptional regulation of the human cytochrome P450IIEI gene. J Biochem 110:559–565

    PubMed  CAS  Google Scholar 

  • Hong J-Y, Pan J, Gonzales FJ, Gelboin HV, Yang CS (1987) The induction of a specific form of cytochrome P-450 (P-450j) by fasting. Biochem Biophys Res Commun 142:1077–1083

    Article  PubMed  CAS  Google Scholar 

  • Ingelman-Sundberg M, Johansson I, Yin H, Terelius Y, Eliason E, Clot P, Albano E (1993) Ethanol-inducible cytochrome P4502E1: Genetic polymorphism, regulation, and possible role in the etiology of alcohol-induced liver disease. Alcohol 10:447–452

    Article  PubMed  CAS  Google Scholar 

  • Johansson I, Ingelman-Sundberg M (1988) Benzene metabolism by ethanol-, acetone-, and benzene-inducible cytochrome P-450 (IIE1) in rat and rabbit liver microsomes. Cancer Res 48(19):5387–5390

    PubMed  CAS  Google Scholar 

  • Kato S, Shields PG, Caporaso NE, Hoover RN, Trump BF, Sugimura H, Weston A, Harris CC (1992) Cytochrome P4502E1 genetic polymorphisms, racial variation, and lung cancer risk. Cancer Res 52:6712–6715

    PubMed  CAS  Google Scholar 

  • Kharasch ED, Thummel KE (1993) Identification of cytochrome P450 2E1 as the predominant enzyme catalyzing human liver microsomal defluorination of sevoflurane, isoflurane, and methoxyflurane. Anesthesiol 79:795–807

    Article  CAS  Google Scholar 

  • Konishi T, Calvillo M, Leng A-S, Feng J, Lee T, Lee H, Smith JL, Sial SH, Berman N, French S, Eysselein V, Lin K-M, Wan Y-JY (2003) The ADH3*2 and CYP2E1 c2 alleles increase the risk of alcoholism in Mexican American men. Exp Mol Pathol 74:183–189

    Article  PubMed  CAS  Google Scholar 

  • Koop DR, Casazza JP (1985) Identification of ethanol-inducible P-450 isozyme 3a as the acetone and acetol monooxygenase of rabbit microsomes. J Biol Chem 260:13607–13612

    PubMed  CAS  Google Scholar 

  • Lieber CS (1997) Cytochrome P-4502E1: its physiological and pathological role. Physiol Rev 77(2):517–543

    PubMed  CAS  Google Scholar 

  • Liu S, Park JY, Schantz SP, Stern JC, Lazarus P (2001) Elucidation of CYP2E1 5′ regulatory RsaI/PstI allelic variants and their role in risk for oral cancer. Oral Oncol 37:437–445

    Article  PubMed  CAS  Google Scholar 

  • Lu AYH, Levin W (1974) The resolution and reconstitution of the liver microsomal hydroxylation system. Biochem Biophys Acta 344:205–240

    PubMed  CAS  Google Scholar 

  • Neuhaus T, Ko Y-D, Lorenzen K, Fronhoffs S, Harth V, Bröde P, Vetter H, Bolt HM, Pesch B, Brüning T (2004) Association of cytochrome P450 2E1 Polymorphisms and head and neck squamous cell cancer. Toxicol Lett 151:273–282

    Article  PubMed  CAS  Google Scholar 

  • Nishimoto IN, Hanaoka T, Sugimura H, Nagura K, Ihara M, Li X-J, Arai T, Hamada GS, Kowalski LB, Tsugane S (2000) Cytochrome P450 2E1 polymorphism in gastric cancer in Brazil: cas-control studies of Japanese Brazilians and non-Japanese Brazilians. Cancer Epidem Biomark Prev 9:675–680

    CAS  Google Scholar 

  • Omer B, Ozbek U, Akkose A, Kilic G (2001) Genetic polymorphism of cytochrome P450 2E1 in the Turkish population. Cell Biochem Funct 19:273–275

    Article  PubMed  CAS  Google Scholar 

  • Oyama T, Kawamato T, Mizoue T, Sugio K, Kodama Y, Mitsudomi T, Yasumoto K (1997) Cytochrome P4502E1 polymorphism as a risk factor for lung cancer: in relation to p53 gene mutation. Anticancer Res 17:583–588

    PubMed  CAS  Google Scholar 

  • Persson I, Johansson I, Lou YC, Yue QY, Duan LS, Bertilsson L, Ingelman-Sundberg M (1999) Genetic polymorphism of xenobiotic metabolizing enzymes among Chinese kung cancer patients. Int J Cancer 81:325–329

    Article  PubMed  CAS  Google Scholar 

  • Peter H, Deutschmann S, Reichel C, Hallier E (1989) Metabolism of methyl chloride by human erythrocytes. Arch Toxicol 72:454–455

    Google Scholar 

  • Peter R, Böker R, Beaune PH, Iwasaki M, Guengerich FP, Yang CS (1990) Hydroxylation of chlorzoxazone as a specific probe for human liver cytochrome P-450IIEI. Chem Res Toxicol 3:566–573

    Article  PubMed  CAS  Google Scholar 

  • Pinarbasi H, Silig Y, Seyfikli Z, Celik VK, Pinarbasi E (2001) Genetic polymorphism of GSTM1 in Turkish lung cancer patients. Toxicol Lett 123(Suppl 1):115

    Google Scholar 

  • Quinones L, Lucas D, Godoy J, Caceres D, Berthou F, Varela N, Lee K, Acevedo C, Martinez L, Aguilera AM, Gil L (2001) CYP1A1, CYP2E1 and GSTM1 genetic polymorphisms. The effect of single and combined genotypes on lung cancer susceptibility in Chilean people. Cancer Lett 174:35–44

    Article  PubMed  CAS  Google Scholar 

  • Sikdar N, Mahmud ASk, Paul RR, Roy B (2003) Polymorphism in CYP1A1 and CYP2E1 genes and susceptibility to leukoplakia in Indian tobacco users. Cancer Lett 195(1):33–42

    Article  PubMed  CAS  Google Scholar 

  • Song BJ, Matsunaga T, Hardwick JP, Park SS, Veech RL, Yang CS, Gelboin HV, Gonzales FJ (1987) Stabilization of cytochrome P450j messenger ribonucleic acid in the rat. Mol Endocrinol 1:542–547

    Article  PubMed  CAS  Google Scholar 

  • Thier R, Lewalter J, Selinski S, Bolt HM (2002) Possible impact of human CYP2E1 polymorphisms on the metabolism of acrylonitrile. Toxicol Lett 128:249–255

    Article  PubMed  CAS  Google Scholar 

  • Uematsu F, Ikawa S, Kikuchi H, Sagami I, Kanamaru R, Abe T, Satoh K, Motomiya M, Watanabe M (1994) Restriction fragment length polymorphism of the human CYP2E1 (cytochrome P450IIE1) gene and susceptibility to lung cancer: possible relevance to low smoking exposure. Pharmacogenet 4(2):58–63

    CAS  Google Scholar 

  • Uematsu F, Kikuchi H, Motomiya M, Abe T, Sagami I, Ohmachi T, Wakui A (1991) Association between restriction fragment length polymorphism of the human cytochrome P450 2E1 gene and susceptibility to lung cancer. Jpn J Cancer Res 82:254–256

    PubMed  CAS  Google Scholar 

  • Umeno M, McBridge OW, Yang CS, Gelboin HV, Gonzales FJ (1988) Human ethanol-inducible P450IIEI: complete gene sequence, promoter characterization, chromosome mapping and cDNA-directed expression. Biochemistry 27:9006–9013

    Article  PubMed  CAS  Google Scholar 

  • Vodicka P, Soucek P, Tates AD, Dusinska M, Sarmanova J, Zamecnikova M, Vodickova L, Koskinen M, Zwart FA, Natajaran AT, Hemminki K (2001) Association between genetic polymorphisms and biomarkers in styrene-exposed workers. Mutat Res 482:89–103

    PubMed  CAS  Google Scholar 

  • Wang S-L, Lee H, Chen K-W, Tsai K-J, Chen C-Y, Lin P (1999) Cytochrome P4502E1 genetic polymorphisms and lung cancer in a Taiwanese population. Lung Cancer 26:27–34

    Article  PubMed  CAS  Google Scholar 

  • Watanabe J, Hayashi S, Nakachi K, Imai K, Suda Y, Sekine T, Kawajiri K (1990) PstI and RsaI RFLPs in complete linkage disequilibrium at the CYP2E gene. Nucleic Acids Res 18(23):7194

    Article  PubMed  CAS  Google Scholar 

  • Wu X, Amos CI, Kemp BL, Shi H, Jiang H, Wan Y, Spitz MR (1998) Cytochrome P450 2E1 DraI polymorphism in lung cancer in minority populations. Cancer Epidemiol Biomark Prev 7:13–18

    CAS  Google Scholar 

  • Wu X, Shi H, Jiang H, Kemp B, Hong WK, Delclos GL, Spitz MR (1997) Associations between cytochrome P4502E1 genotype, mutagen sensitivity, cigarette smoking and susceptibility to lung cancer. Carcinogenesis 18(5):967–73

    Article  PubMed  CAS  Google Scholar 

  • Yang B-M, O’Reilly DA, Demaine AG, Kingsnorth AN (2001) Study of polymorphisms in the CYP2E1 gene in patients with alcoholic pancreatitis. Alcohol 23:91–97

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgments

The authors thank to volunteers donating blood, Dr. Nusret Taheri, Dr. Sibel Yıldız and Middle East Technical University Health Center for their help in collecting blood samples. This study was supported in part by Middle East Technical University Research Project Fund (Project number: BAP-2003-07-02-00-40).

Author information

Authors and Affiliations

  1. Biochemistry Graduate Programme and Department of Biological Sciences, Middle East Technical University, 06531, Ankara, Turkey

    Gulen Ulusoy, Emel Arinç & Orhan Adali

Authors
  1. Gulen Ulusoy
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Emel Arinç
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Orhan Adali
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Emel Arinç.

Additional information

An account of this work has been presented at the 31st Federation of European Biochemical Societies (FEBS) Congress, in Istanbul, Turkey, on June 24–29, 2006.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ulusoy, G., Arinç, E. & Adali, O. Genotype and allele frequencies of polymorphic CYP2E1 in the Turkish population. Arch Toxicol 81, 711–718 (2007). https://doi.org/10.1007/s00204-007-0200-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00204-007-0200-y

Keywords

Search

Navigation